Mortality by COVID-19 Before Vaccination - One Year Experience of Hospitalized Patients in Madrid

被引:12
|
作者
Moreno-Torres, Victor [1 ]
Munoz-Serrano, Alejandro [1 ]
Calderon-Parra, Jorge [1 ]
Mills-Sanchez, Patricia [1 ]
Pintos-Pascual, Ilduara [1 ]
Rodriguez-Olleros, Celia [1 ]
Ibanez-Estellez, Fatima [1 ]
Tung-Chen, Yale [1 ]
Ramos-Martinez, Antonio [1 ,2 ]
Vargas-Nunez, Juan A. [1 ,2 ]
Cuervas-Mons, Valentin [1 ,2 ]
de Mendoza, Carmen [1 ,3 ]
机构
[1] Hosp Univ Puerta Hierro Majadahonda, Internal Med Dept, Madrid, Spain
[2] Univ Autonoma Madrid, Sch Med, Med Dept, Madrid, Spain
[3] CEU San Pablo Univ, Madrid, Spain
关键词
COVID-19; mortality rate; Spain; comorbidities;
D O I
10.1016/j.ijid.2022.01.043
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim of the study was to analyze the mortality and characteristics of deceased patients with COVID-19 during the first year of the pandemic. Methods: All admissions owing to COVID-19 at a tertiary hospital in Madrid were analyzed. Three waves were considered: March 2020 to June 2020, July 2020 to November 2020, and December 2020 to April 2021. Results: A total of 3,676 patients were identified. Among inpatients, no differences regarding age, sex, length of admission, or mortality were found between the 3 waves (p >0.05). The overall mortality rate was 12.9%. Among deceased patients, the median age was 82 years and the median Charlson Comorbidity Index was 6. Considering the main predictors for mortality by COVID-19 (age, sex, and concomitant comorbidities), only patients with previous lung disease were more prevalent in the third period (p <0.01). Finally, higher intensive care unit admission rates, a lower rate of patients coming from nursing homes, and a lower rate of patients with dementia were noted in the third period (p <0.05) among deceased patients. Conclusion: One year after the onset of the pandemic, the mortality rate of hospitalized patients and the profile of non-survivors have not changed significantly. In the absence of vaccine benefits, advanced age and multiple pathologies are uniform characteristics of non-survivors. (C) 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:339 / 343
页数:5
相关论文
共 50 条
  • [41] Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients
    Daniel Morell-Garcia
    David Ramos-Chavarino
    Josep M. Bauça
    Paula Argente del Castillo
    Maria Antonieta Ballesteros-Vizoso
    Luis García de Guadiana-Romualdo
    Cristina Gómez-Cobo
    J. Albert Pou
    Rocío Amezaga-Menéndez
    Alberto Alonso-Fernández
    Isabel Llompart
    Ana García-Raja
    Scientific Reports, 11
  • [42] Sex Differences in Thrombosis and Mortality in Patients Hospitalized for COVID-19
    Wilcox, Tanya
    Smilowitz, Nathaniel R.
    Seda, Bilaloglu
    Xia, Yuhe
    Hochman, Judith
    Berger, Jeffrey S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 170 : 112 - 117
  • [43] Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
    Kang, Min-Kyu
    Lee, Yu-Rim
    Song, Jeung-Eun
    Kweon, Young-Oh
    Tak, Won-Young
    Jang, Se-Young
    Park, Jung-Gil
    Park, Soo-Young
    DIAGNOSTICS, 2022, 12 (09)
  • [44] Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
    Nadkarni, Girish N.
    Lala, Anuradha
    Bagiella, Emilia
    Chang, Helena L.
    Moreno, Pedro R.
    Pujadas, Elisabet
    Arvind, Varun
    Bose, Sonali
    Charney, Alexander W.
    Chen, Martin D.
    Cordon-Cardo, Carlos
    Dunn, Andrew S.
    Farkouh, Michael E.
    Glicksberg, Benjamin S.
    Kia, Arash
    Kohli-Seth, Roopa
    Levin, Matthew A.
    Timsina, Prem
    Zhao, Shan
    Fayad, Zahi A.
    Fuster, Valentin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (16) : 1815 - 1826
  • [45] Hyponatremia, Inflammation, and Hospital Mortality in Hospitalized COVID-19 Patients
    Ayus, Juan Carlos
    Moritz, Michael L.
    Lee, Kyung Min
    Caputo, Daniel
    Borda, Maria E.
    Go, Alan S.
    Eghi, Carlos
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 375 - 375
  • [46] Factors affecting mortality in geriatric patients hospitalized with COVID-19
    SOYTAS, Rabia B. A. G.
    UNAL, Damla
    ARMAN, Pinar
    SUZAN, Veysel
    Gedik, Tugce Emiroglu
    CAN, Gunay
    KORKMAZER, Bora
    KARAALI, Ridvan
    BOREKCI, Sermin
    KUSKUCU, Mert Ahmet
    YAVUZER, Hakan
    ERDINCLER, Deniz S. U. N. A.
    Doventas, Alper
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (02) : 454 - 463
  • [47] Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients
    Bahl, Amit
    Johnson, Steven
    Chen, Nai-Wei
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (06) : 1593 - 1603
  • [48] Risk factors for COVID-19 mortality in hospitalized patients in Bolivia
    Limachi-Choque, Jhonny
    Guitian, Javier
    Leyns, Christine
    Guzman-Rivero, Miguel
    Eid, Daniel
    IJID REGIONS, 2023, 9 : 95 - 101
  • [49] Association of race/ethnicity with mortality in patients hospitalized with COVID-19
    Richardson, Safiya
    Martinez, Johanna
    Hirsch, Jamie S.
    Cerise, Jane
    Lesser, Martin
    Roswell, Robert O.
    Davidson, Karina W.
    PLOS ONE, 2022, 17 (08):
  • [50] Urine biomarkers for the prediction of mortality in COVID-19 hospitalized patients
    Morell-Garcia, Daniel
    Ramos-Chavarino, David
    Bauca, Josep M.
    Argente del Castillo, Paula
    Antonieta Ballesteros-Vizoso, Maria
    Garcia de Guadiana-Romualdo, Luis
    Gomez-Cobo, Cristina
    Albert Pou, J.
    Amezaga-Menendez, Rocio
    Alonso-Fernandez, Alberto
    Llompart, Isabel
    Garcia-Raja, Ana
    SCIENTIFIC REPORTS, 2021, 11 (01)